FY2025 · period end Dec '25 · from the 10-K filed Feb 17, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | $8.16B | $7.95B | $6.89B |
| Gross Profit | — | — | $1.75B | $1.49B | $1.33B |
| Operating Income | $1.02B | $0.88B | $0.96B | $0.76B | $0.31B |
| Net Income | — | — | $0.64B | $0.49B | $0.12B |
| EPS (Diluted) | — | — | $9.60 | $7.34 | $1.73 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $7.90B | $7.44B | $7.64B | $7.56B | $7.00B |
| Total Liabilities | $3.53B | $3.55B | $3.99B | $4.30B | $3.77B |
| Stockholders' Equity | $4.29B | $3.82B | $3.55B | $3.16B | $3.12B |
| Cash & Equivalents | $1.03B | $1.00B | $0.40B | $0.24B | $0.33B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.94B | $1.44B | $1.06B | $0.15B | $0.39B |
| Capital Expenditures | $0.43B | $0.29B | $0.31B | $0.30B | $0.30B |
| Free Cash Flow | $0.51B | $1.14B | $0.74B | negative: -$0.15B | $0.09B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | 21.4% | 18.8% | 19.3% |
| Operating Margin | — | — | 0.1% | 0.1% | 0.0% |
| Net Margin | — | — | 0.1% | 0.1% | 0.0% |
| Return on Equity | 18.0% | 17.5% | 19.2% | 15.7% | 3.8% |
| Return on Assets | 9.5% | 8.6% | 8.5% | 6.8% | 1.7% |
| Debt / Equity | 0.41× | 0.47× | 0.49× | 0.61× | 0.56× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001628280-26-054722 | Jun 30, 2026 | Aug 7, 2026 | Aug 7, 2026 17:19 UTC | EDGAR |
| 8-K | 0001628280-26-052104 | Aug 4, 2026 | Aug 4, 2026 | Aug 4, 2026 10:09 UTC | EDGAR |
| 8-K | 0001046257-26-000230 | Jul 28, 2026 | Jul 28, 2026 | Jul 28, 2026 20:15 UTC | EDGAR |
| 8-K | 0001046257-26-000224 | Jul 3, 2026 | Jul 6, 2026 | Jul 6, 2026 10:12 UTC | EDGAR |
| 8-K | 0001046257-26-000210 | Jun 30, 2026 | Jun 30, 2026 | Jun 30, 2026 10:45 UTC | EDGAR |
| 8-K | 0001628280-26-045521 | Jun 24, 2026 | Jun 25, 2026 | Jun 25, 2026 20:18 UTC | EDGAR |
| 8-K | 0001046257-26-000204 | Jun 7, 2026 | Jun 11, 2026 | Jun 11, 2026 20:15 UTC | EDGAR |
| 8-K | 0001628280-26-041921 | Jun 8, 2026 | Jun 9, 2026 | Jun 9, 2026 20:25 UTC | EDGAR |
Direct links to SEC EDGAR. INGR has additional filings available on the SEC site.
6 numbers Ingredion Inc later changed — same XBRL tag, both filings linked.
Revenue from Contract with Customer, Excluding Assessed Tax·Q1 2019
Notable restatementwas$1.4B
Revised up in a 10-K. Any P/S built on the original was 7.6% too high.
Revenue from Contract with Customer, Excluding Assessed Tax·Q2 2019
Notable restatementwas$1.4B
Revised up in a 10-K. Any P/S built on the original was 7.5% too high.
Revenue from Contract with Customer, Excluding Assessed Tax·Q3 2019
Notable restatementwas$1.5B
Revised up in a 10-K. Any P/S built on the original was 7.4% too high.
Revenue from Contract with Customer, Excluding Assessed Tax·Q3 2018
Notable restatementwas$1.4B
Revised up in a 10-K. Any P/S built on the original was 7.2% too high.
Revenue from Contract with Customer, Excluding Assessed Tax·3 months to Dec 2018
Notable restatementwas$1.4B
Revised up in a 10-K. Any P/S built on the original was 7.2% too high.
Revenue from Contract with Customer, Excluding Assessed Tax·Q1 2018
Notable restatementwas$1.5B
Revised up in a 10-K. Any P/S built on the original was 7.1% too high.
INGR is not the only one.
See every restatement we've found across the market — or get an alert the next time INGR revises a number.
Restatements are detected by comparing every vintage of a fact across all of Ingredion Inc's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows INGR's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Ingredion Inc — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on INGR yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on INGR and publish the result to your public profile.
Ask about Ingredion Inc
Continue in Workspace — cited answers on INGR, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs